AMJ Podcast | Episode 3: Shifting the Silence: The Evolving Landscape in Pulmonary Fibrosis

EMJ Podcast: Insights For Healthcare Professionals

This content was funded by Boehringer Ingelheim, who had no influence or involvement in the development of the content. This material is intended for U.S. healthcare professionals.

Pulmonary fibrosis remains one of the most challenging respiratory diseases – often underdiagnosed, undertreated, and misunderstood. In this AMJ podcast, Ayodeji Adegunsoye and Toby Maher share their expert perspectives on how the field is changing, how recent data are shaping clinical decision-making, and why holistic, patient-centered care is critical.

Chapters:

1. 03:02 – 15:34 – A Decade Without New Options
2. 15:34 – 27:47 – Understanding the Latest Clinical Trial Data
3. 27:47 – 39:28 – From Hesitancy to Action: Reaching the Community Clinician
4. 39:28 – 54:10 – Psychosocial Support and Patient-Centered Care
5. 54:10 – 01:02:07 – The Role of Primary Care in ILD Diagnosis
6. 01:02:07 – 1:07:48 – Call to Action

Speakers:

• Ayodeji Adegunsoye, MD, PhD – Assistant Professor of Medicine, Biological Sciences Division, University of Chicago, Illinois, USA
• Toby Maher, MD, PhD – Professor of Clinical Medicine, Keck School of Medicine, University of Southern California, USA